AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alepride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alester Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Alepride M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Alepride M 1mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Alepride M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Alepride M 1mg/500mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Alepride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Alepride M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Alepride M 1mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Alepride M 1mg/500mg Tablet SR works:

Alepride M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Alepride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Alepride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Alepride M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Alepride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Alepride M 1mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Alepride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Alepride M 1mg/500mg Tablet SR :

Should you forget to take your Alepride M 1mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alepride M 1mg/500mg Tablet SR

LabelValue
Addictive None.
Treatment Category Medication for diabetes

FAQs on Alepride M 1mg/500mg Tablet SR

Retain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Alepride M 1mg/500mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more prevalent in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Alepride M 1mg/500mg Tablet SR and seek immediate medical attention.
Alepride M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Alepride M 1mg/500mg sustained-release tablets may cause common adverse reactions including hypoglycemia, altered taste perception, nausea, abdominal pain, diarrhea, and headache. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged use of Alepride M 1mg/500mg SR tablets can lead to Vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Alepride M 1mg/500mg Extended-Release Tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Alepride M 1mg/500mg SR tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also raises the likelihood of lactic acidosis.
Alepride M 1mg/500mg Tabl...
41
MRP 50
18% off